Dr. Michael Schivo is a Director of the Internal Medicine Residency Research Track, Co-Director of Comprehensive COPD Clinic, Assistant Professor of the Division of Clinical Internal Medicine, and Associate Professor of Medicine. In research, Dr. Schivo focuses on the analysis of exhaled and emitted volatile organic compounds (VOC) with the aims of non-invasive diagnostics, disease monitoring, and evaluation of therapeutic response.

Positions at UC Davis

• Director, Internal Medicine Residency Research Track
• Co-Director Comprehensive COPD Clinic;
• Assistant Professor, Division of Clinical Internal Medicine
• Associate Professor of Medicine

Areas of Expertise

• In-vitro epithelial models
• Human subject studies

Major Research Papers

McCartney MM, Linderholm AL, Yamaguchi MS, Falcon AK, Harper RW, Thompson GR, Ebeler SE, Kenyon NJ, Davis CE, Schivo M. Predicting influenza and rhinovirus infections in airway cells utilizing volatile emissions. J Infect Dis. 2021 Apr 15;224(10):1742–50. doi:10.1093/infdis/jiab205. Epub ahead of print. PMID:33858010.

Mitra A, Dwyre DM, Schivo M, Thompson GR 3rd, Cohen SH, Ku N, Graff JP. Leukoerythroblastic reaction in a patient with COVID-19 infection. Am J Hematol. 2020 Aug;95(8):999-1000. doi:10.1002/ajh.25793. Epub 2020 Apr 6. PMID:32212392.

Sanville B, Corbett R, Pidcock W, Hardin K, Sebat C, Nguyen MV, Thompson GR, Haczku A, Schivo M, Cohen S. A Community-transmitted Case of Severe Acute Respiratory Distress Syndrome (SARS) Due to SARS-CoV-2 in the United States. Clin Infect Dis. 2020 Nov 19;71(16):2222-2226. doi:10.1093/cid/ciaa347. PMID:32227197.

Fung AG, Tan LD, Duong TN, Schivo M, Littlefield L, Delplanque JP, Davis CE, Kenyon NJ. Design and Benchmark Testing for Open Architecture Reconfigurable Mobile Spirometer and Exhaled Breath Monitor with GPS and Data Telemetry. Diagnostics (Basel). 2019 Aug 21;9(3):100. doi:10.3390/diagnostics9030100. PMID:31438639